NCT00232089View on ClinicalTrials.gov

Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia

PHASE3CompletedINTERVENTIONAL
Enrollment

1,296

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Dyspepsia
Interventions
DRUG

Tegaserod

Trial Locations (1)

07936-108

Novartis, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY